Hypercoagulable states and central retinal vein occlusion

• Published in: Current opinion in pulmonary medicine Vol. 9; no. 5; p. 385
• Main Authors: Lahey, J Michael, Kearney, John J, Tunc, Murat
• Format: Journal Article
• Language: English
• Published: United States 01.09.2003
• Subjects: Biomarkers - blood; Humans; Predictive Value of Tests; Retinal Vein Occlusion - blood; Retinal Vein Occlusion - diagnosis; Retinal Vein Occlusion - etiology; Risk Factors; Thrombosis - blood; Thrombosis - complications; Thrombosis - diagnosis
• ISSN: 1070-5287
• DOI: 10.1097/00063198-200309000-00008

Central retinal vein occlusion is a common cause of permanent visual loss. Work up and laboratory evaluation of patients requires the clinician to rule out hypertension, diabetes, hyperlipidemia, and glaucoma. Patients without an identifiable risk factor are often subject to extensive testing for primary and secondary thrombophilias. The purpose this paper is to review the literature to determine which of these tests is associated with central retinal vein occlusion. Antiphospholipid antibodies and elevated plasma homocysteine levels appear to be the tests associated most commonly in patients with central retinal vein occlusion in most controlled studies. Primary thrombophilias are found rarely when screening patients with central retinal vein occlusion. Extensive testing for thrombophilias is not warranted in the vast majority of patients with central retinal vein occlusion. Older patients with any of the common vascular risk factors do not require thrombophilic screening. By carefully selecting the patients who are evaluated for thrombophilias, the likelihood of finding true-positive tests is increased.